Login / Signup

Distributional Cost-Effectiveness of Equity-Enhancing Gene Therapy in Sickle Cell Disease in the United States.

George GoshuaCecelia L CalhounSatoko ItoLyndon P JamesAndrea LuvianoLakshmanan KrishnamurtiAnkur Pandya
Published in: Annals of internal medicine (2023)
Yale Bernard G. Forget Scholars Program and Bunker Endowment.
Keyphrases
  • sickle cell disease
  • gene therapy
  • quality improvement
  • global health
  • public health